Showing 181 - 200 results of 27,551 for search '(( e point decrease ) OR ((( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 non decrease ))))', query time: 0.97s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193

    DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

    Published 2021
    “…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200